“Diversity in clinical trials is not only an ethical imperative; it is also good science. It allows us to understand how treatments affect different populations and how we can solve these differences,” said Estelamari Rodriguez, MD.

We spoke with Stephen Paul Cohen, MD, to gain further insight into how pain affects women with rheumatic diseases and the unmet needs in this area.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Back pain is among the most common forms of pain patients endure, and can severely alter their quality of life and ability to perform basic tasks. What risk factors for back pain should patients know?

Despite misconceptions, geriatric LGBTQ+ adults who live in rural communities require culturally competent care tailored to their unique needs.